Physician profile
Robert H Biggs
NPI 1164417721
$730.49
in general payments reported to CMS, 2019-2025
11 companies · $66.76 in 2025
The $66.76 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $257 · 2021: $13.71 · 2022: $31.65 · 2023: $26.17 · 2024: $84.64 · 2025: $66.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $321.72 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $99.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $75.27 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.18 | 2020 | |
| Abiomed | $44.96 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $38.16 | 2021-2025 | Camzyos |
| Scpharmaceuticals INC. | $26.90 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.43 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.41 | 2025 | Onpattro |
| Kowa Pharmaceuticals America, INC. | $14.84 | 2022 | |
| Pfizer INC. | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Biggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.